Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
135 participants
OBSERVATIONAL
2004-03-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The rate of HIV transmission form mother to child in our study is 6,7%(9?135). In utero is 1,5% and 5% in gestation.
* Sixty-nine percent of HIV pregnant women were get antiretroviral. Most of them (84%) get nevirapine at delivery (6 children HIV infected). The rest get triple antiretroviral(2 infected child).
* Selective cesarean section not comment for HIV pregnant women.
* Non breast feeding were recommended and all mothers chose formula feeding to their child so that we had no data for transmission by breast milk.
* Two HIV infected child die before 18months versus non die in uninfected child.
* CD4 T cell count lower than 200/microliter were observed dominate in mother infected child.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
For their child: the child had tested HIV at list 3 time one at birth, one at 12 or 18 months and one in between.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
National Institute of Hygiene and Epidemiology, Vietnam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
National Institute of Hygiene and Epidemiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phung D Cam, MD,PhD
Role: STUDY_CHAIR
National Institute of Hygiene and Epidemiology, Vietnam
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Obstetric and Gynaecology Hospital
Hanoi, Hanoi, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tran Thi Thanh Ha, Pham Le Tuan, Nguyen Huy Bao et al. Successful reduction of mother-to-child transmission of HIV-1 by nevirapin and non-breastfeeding in Hanoi and Haiphong. Retrovirology 2008; 5, S1: 26-27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3RF-1/MoST-Sida
Identifier Type: -
Identifier Source: secondary_id
3RF-1
Identifier Type: -
Identifier Source: org_study_id